CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA

Journal of Infectious Diseases

Volumn 205, Issue 7, 2012, Pages 1095-1099

  Shamay, Meir ^a   Hand, Nicholas ^a   Lemas, M Victor ^a   Koon, Henry B ^b   Krown, Susan E ^c   Wrangle, John ^a   Desai, Prashant ^a   Ramos, Juan Carlos ^d   Ambinder, Richard F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Seidman Cancer Center   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN; VIRUS DNA;

ARTICLE; ASCITES; BLOOD SAMPLING; CANCER CELL CULTURE; CELL FREE SYSTEM; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA METHYLATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRION; VIRUS DETECTION; VIRUS GENOME;

DNA, VIRAL; DNA-CYTOSINE METHYLASES; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, PRIMARY EFFUSION; METHYLATION; SARCOMA, KAPOSI;

EID: 84858205399     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis032     Document Type: Article

References (15)

1. Moore PS, Chang Y. KSHV: forgotten but not gone. Blood 2011; 117:6973-4.
2. Uldrick TS, Whitby D. Update on KSHV epidemiology, Kaposi sarcoma pathogenesis, and treatment of Kaposi sarcoma. Cancer Lett 2011; 305:150-62.
3. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11:426-37.
4. Campbell TB, Borok M, White IE, et al. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe. Clin Infect Dis 2003; 36:1144-51. (Pubitemid 36549635)
5. Lin L, Lee JY, Kaplan LD, et al. Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol 2009; 27:2496-502.
6. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996; 88:2648-54. (Pubitemid 26327517)
7. Koon HB, Fingleton B, Lee JY, et al. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr 2011; 56:64-8.
8. Günther T, Grundhoff A. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 2010; 6:e1000935.
9. Silva JM, Dominguez G, Garcia JM, et al. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 1999; 59:3251-6. (Pubitemid 29316030)
10. Wagner-Johnston ND, Gellert L, Gocke CD, et al. Clonal immunoglobulin DNA in the plasma of patients with AIDS lymphoma. Blood 2011; 117:4860-2.
11. Campbell TB, Staskus KA, Folkvord J, et al. Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected cells in KSHV/ HIV-1-coinfected subjects without KSHV-associated diseases. J Infect Dis 2005; 191:367-71. (Pubitemid 40139761)
12. Leung SF, Zee B, Ma BB, et al. Plasma Epstein-Barr viral deoxy-ribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol 2006; 24:5414-8. (Pubitemid 46623174)
13. Penin RM, Fernandez-Figueras MT, Puig L, Rex J, Ferrandiz C, Ariza A. Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27(KIP1) down-regulation. Mod Pathol 2002; 15:1227-35. (Pubitemid 35435142)
14. Carbone A, Gloghini A, Bontempo D, et al. Proliferation in HHV- 8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1). Am J Pathol 2000; 156:1209-15. (Pubitemid 30659999)
15. Yegnasubramanian S, Lin X, Haffner MC, DeMarzo AM, Nelson WG. Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation. Nucleic Acids Res 2006; 34:e19.